Published in

Wiley, International Journal of Cancer, 8(135), p. 1884-1897, 2014

DOI: 10.1002/ijc.28824

Links

Tools

Export citation

Search in Google Scholar

Adherence to Mediterranean diet and risk of cancer: A systematic review and meta-analysis of observational studies: Mediterranean diet and cancer risk

Journal article published in 2014 by Lukas Schwingshackl ORCID, Georg Hoffmann
This paper is available in a repository.
This paper is available in a repository.

Full text: Download

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

The aim of this research study was to meta-analyze the effects of adherence to Mediterranean Diet (MD) on overall cancer risk, and different cancer types. Literature search was performed using the electronic databases MEDLINE, SCOPUS, and EMBASE until 10th January 2014. Inclusion criteria were: cohort or case-control studies. Study specific risk ratios (RR) were pooled using a random effect model by the Cochrane software package Review Manager 5.2. 21 cohort studies including 1,368,736 subjects, and 12 case-control studies with 62,725 subjects met the objectives and were enclosed for meta-analyses. The highest adherence to MD category resulted in a significantly risk reduction for overall cancer mortality/incidence [cohort; RR: 0.90, 95% CI 0.86 to 0.95, p < 0.0001; I2=55%], colorectal [cohort/case control; RR: 0.86, 95% CI 0.80 to 0.93, p < 0.0001; I2=62%], prostate [cohort/case control; RR: 0.96, 95% CI 0.92 to 0.99, p = 0.03; I2=0%], and aerodigestive cancer [cohort/case-control studies; RR: 0.44, 95% CI 0.26 to 0.77, p = 0.003; I2=83%]. Non-significant changes could be observed for breast cancer, and gastric cancer, and pancreatic cancer. The Egger regression tests provided limited evidence of substantial publication bias. High adherence to a Mediterranean diet is associated with a significant reduction in the risk of overall cancer mortality (10%), colorectal cancer (14%), prostate cancer (4%), and aerodigestive cancer (56%). © 2014 Wiley Periodicals, Inc.